Otonomy (OTIC:NASDAQ) Investor Relations Material

Overview

Otonomy is a clinical-stage biopharmaceutical company that develops and commercializes therapeutics for ear diseases and disorders in the US and Canada. Its lead product candidate, AuriPro, completed Phase III clinical trials for the treatment of pediatric patients with middle ear effusion or fluid during tympanostomy tube placement surgery.

Annual Reports

Frequently Asked Questions

What is Otonomy's ticker?

Otonomy's ticker is OTIC

What exchange is Otonomy traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Otonomy's headquarters?

They are based in San Diego, California

How many employees does Otonomy have?

There are 51-200 employees working at Otonomy

What is Otonomy's website?

It is otonomy.com

What type of sector is Otonomy?

Otonomy is in the Healthcare sector

What type of industry is Otonomy?

Otonomy is in the Biotechnology industry

Who are Otonomy's peers and competitors?

The following five companies are Otonomy's industry peers:

- Veru

- Brickell Biotech, Inc.

- Reliv International, Inc.

- Incyte

- Tonix Pharmaceuticals Holding Corp.